SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001634432-20-000032
Filing Date
2020-08-04
Accepted
2020-08-04 07:36:53
Documents
3
Period of Report
2020-06-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sbbp-20200630x8k.htm 8-K 29220
2 EX-99.1 sbbp-20200630ex991949ae0.htm EX-99.1 401459
3 GRAPHIC sbbp-20200630ex991949ae0001.jpg GRAPHIC 4901
  Complete submission text file 0001634432-20-000032.txt   438826
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 8-K | Act: 34 | File No.: 001-37569 | Film No.: 201070967
SIC: 2834 Pharmaceutical Preparations